genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
DNA
X and Y: Synthorx Expands the Genetic Code to Create Optimized…
Cancer
Set Phase Separation to Stun
Gene Therapy
A New Vision for Gene Therapy
OMICs
Can Encodia Become the Illumina of Proteomics?
Alzheimers
Cognition Thinks It Has an Alzheimer’s Blockbuster
News
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
News
Portable NMR Sensor Detects Fatty Liver Disease and Fibrosis in Mice
CRISPR-Cas9
CRISPR Screening IDs Factors for Turning Stem Cells into Neurons
Bioprocessing
ViGeneron and WuXi Form Strategic Manufacturing Partnership
Insights
All
Trends for 2020
OMICs
Genomics Analysis Moves to the Next Level
December 2020 Vol. 40 No. 12
Viral Clearance in the Manufacture of Biologics
December 2020 Vol. 40 No. 12
Viral Testing in the Era of Continuous Biomanufacturing and COVID-19
December 2020 Vol. 40 No. 12
Viral Safety Testing: Keeping the Fly Out of the Ointment
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
OMICs
Genomics Analysis Moves to the Next Level
December 2020 Vol. 40 No. 12
Advanced Computational Methods Drive Large-Scale Data Analysis in 4D
Magazine
All
Supplement
November 2020 Vol. 40 No. 11
With Synthetic Biology Nature Is All Business
Biobanking
Biobanks Are Becoming Data Banks in the Era of Personalized Medicine
Biobanking
Cryopreservation to Improve Cell Manufacturing and Biobanking
Biobanking
Enabling Scientific Discovery and Healthcare with Biobanks
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
RNAi
RNAi
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
RNAi
Lilly, Dicerna Launch $3.7B+ RNAi Collaboration
RNAi
Alexion, Dicerna Launch $637M+ RNAi Collaboration in Complement-Mediated Diseases
RNAi
Autism Genetic Complexity Comes to Light
RNAi
RNA Editing Website
RNAi
SiVirus
RNAi
RXi Partners with University of Massachusetts Med School on RNAi Therapeutics...
RNAi
ANTIBIOTICS ENHANCE RNAI CAPABILITIES
RNAi
Scientists Trigger Antitumor Immune Responses Using siRNAs
RNAi
Propeller Twist Blog
RNAi
Arrowhead Inks Deals that Focus Firm on Nanomedicines
RNAi
Alnylam and MIT Advance Research on Systemic Delivery of RNAi Therapeutics...
RNAi
BMS Expands Deal to Evaluate Tekmira’s RNAi Delivery Technology
RNAi
“Gangway!” in the Genome Prevents Transcription/Replication Wreckage
RNAi
Anticancer siRNAs Delivered to Cells Using MOF Nanoparticles
RNAi
Alnylam and Novartis Take RNAi Therapeutics Collaboration into Fifth Year
1
2
3
...
6
Page 1 of 6
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Illustration of chromosome 16 showing the 14 fly counterparts of the 25 human genes located in a deletion on the chromosome that is associated with autism risk. Researchers used RNA interference (RNAi) to the reduce the expression of these genes individually and in tandem to test how the interactions of these genes modulate neurodevelopmental symptoms associated with the deletion. Interactions between genes that either enhance or suppress the affect of reduced expression are shown by red or blue lines. [Girirajan Laboratory/Penn State]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul2_2018_PennState_Chromosome16Ilustration4113701011-265x198.jpg "Autism Genetic Complexity Comes to Light")
